More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

OncoSil Signs Commercial Agreement With Hospital In Spain

Apr 28, 2022 at 11:33 PM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Apr 28, 2022 at 11:33 PM EDT

On 6ix: 6ix.com/news/oncosil-signs-commercial-agreement-with-hospital-in-spain

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

In the deck

  • OncoSil Medical — Investor Presentation (April 2022)16 slidesApr 29, 2022

Story so far

  • First Commerical Pancreas Treatment In SpainApr 13, 2022
  • OncoSil achieves first commercial saleOct 22, 2020

Earlier from OncoSil Medical

  • First Commerical Pancreas Treatment In SpainApr 12, 2022
  • Fully-Funded Trial Approved In GermanyMar 27, 2022
  • Half Yearly Report ResultsFeb 22, 2022
  • OncoSil approved for Innovation Funding (NUB) in GermanyFeb 2, 2022
  • PanCO Clinical Study on OncoSil Published in ESMO OpenDec 23, 2021

Later from OncoSil Medical

  • OncoSil Launches $10m Capital RaisingApr 29, 2022
  • Clarification Of Non-Renouncable Entitlement Offer DetailsMay 1, 2022
  • OncoSil Entitlement Offer BookletMay 10, 2022
  • Entitlement Offer Results and Shortfall NotificationJun 9, 2022
  • OncoSil PanCO Clinical Trial Presented At ESMO World WCGICJun 28, 2022
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer